MANCHESTER MANAGEMENT CO LLC 13D and 13G filings for NeuroOne Medical Technologies Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 3:11 pm Sale |
2024-12-31 | 13G | NeuroOne Medical Technologies Corporation NMTC |
MANCHESTER MANAGEMENT CO LLC | 1,583,332 4.900% |
-854,794 (-35.06%) |
Filing |
| 2023-08-01 7:04 pm Purchase |
2023-07-27 | 13G | NeuroOne Medical Technologies Corporation NMTC |
MANCHESTER MANAGEMENT CO LLC | 2,438,126 9.999% |
2,438,126 (New Position) |
Filing |